The longitudinal characterization of immune responses in COVID-19 patients reveals novel prognostic signatures for disease severity, patients’ survival and long COVID
2019-20 coronavirus outbreak
DOI:
10.3389/fimmu.2024.1381091
Publication Date:
2024-07-29T08:21:47Z
AUTHORS (36)
ABSTRACT
SARS-CoV-2 pandemic still poses a significant burden on global health and economy, especially for symptoms persisting beyond the acute disease. COVID-19 manifests with various degrees of severity identification early biomarkers capable stratifying patient based risk progression could allow tailored treatments.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (101)
CITATIONS (7)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....